SEC Comment Letter 0000000000-25-000484 to Z Squared Inc. (COEP)
Z Squared Inc.
Date: Jan. 16, 2025 · CIK: 0001759186 · Accession: 0000000000-25-000484
AI Filing Summary & Sentiment
File numbers found in text: 333-284230
Letter
January 16, 2025 David Mehalick Chief Executive Officer Coeptis Therapeutics Holdings, Inc. 105 Bradford Road, Suite 420 Wexford Pennsylvania 15090 Re:Coeptis Therapeutics Holdings, Inc. Registration Statement on Form S-1 Filed January 10, 2025 File No. 333-284230 Dear David Mehalick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Denis Dufresne
Show Raw Text
January 16, 2025
David Mehalick
Chief Executive Officer
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road, Suite 420
Wexford Pennsylvania 15090
Re:Coeptis Therapeutics Holdings, Inc.
Registration Statement on Form S-1
Filed January 10, 2025
File No. 333-284230
Dear David Mehalick:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Denis Dufresne